Clinical Trial Update: Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating rabeprazole-based sequential-concomitant hybrid therapies for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN